139 related articles for article (PubMed ID: 36194676)
1. New Rufomycins from
Zhou B; Shetye G; Wolf NM; Chen SN; Qader M; Ray GJ; Lankin DC; Cho S; Cheng J; Suh JW; Franzblau SG; McAlpine JB; Pauli GF
Org Lett; 2022 Oct; 24(40):7265-7270. PubMed ID: 36194676
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial Rufomycin Analogues from
Zhou B; Shetye G; Yu Y; Santarsiero BD; Klein LL; Abad-Zapatero C; Wolf NM; Cheng J; Jin Y; Lee H; Suh JW; Lee H; Bisson J; McAlpine JB; Chen SN; Cho SH; Franzblau SG; Pauli GF
J Nat Prod; 2020 Mar; 83(3):657-667. PubMed ID: 32031795
[TBL] [Abstract][Full Text] [Related]
3. Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments.
Zhou B; Achanta PS; Shetye G; Chen SN; Lee H; Jin YY; Cheng J; Lee MJ; Suh JW; Cho S; Franzblau SG; Pauli GF; McAlpine JB
J Nat Prod; 2021 Oct; 84(10):2644-2663. PubMed ID: 34628863
[TBL] [Abstract][Full Text] [Related]
4. Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity.
Kazmaier U; Junk L
Mar Drugs; 2021 Aug; 19(8):. PubMed ID: 34436284
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
6. Antitubercular Ilamycins from Marine-Derived
Sun C; Liu Z; Zhu X; Fan Z; Huang X; Wu Q; Zheng X; Qin X; Zhang T; Zhang H; Ju J; Ma J
J Nat Prod; 2020 May; 83(5):1646-1657. PubMed ID: 32324401
[TBL] [Abstract][Full Text] [Related]
7. NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.
Xie Y; Cai Q; Ren H; Wang L; Xu H; Hong B; Wu L; Chen R
J Nat Prod; 2014 Jul; 77(7):1744-8. PubMed ID: 24964393
[TBL] [Abstract][Full Text] [Related]
8. Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Cai G; Napolitano JG; McAlpine JB; Wang Y; Jaki BU; Suh JW; Yang SH; Lee IA; Franzblau SG; Pauli GF; Cho S
J Nat Prod; 2013 Nov; 76(11):2009-18. PubMed ID: 24224794
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.
Ma J; Huang H; Xie Y; Liu Z; Zhao J; Zhang C; Jia Y; Zhang Y; Zhang H; Zhang T; Ju J
Nat Commun; 2017 Aug; 8(1):391. PubMed ID: 28855504
[TBL] [Abstract][Full Text] [Related]
10. Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis.
Singh SB; Odingo J; Bailey MA; Sunde B; Korkegian A; O'Malley T; Ovechkina Y; Ioerger TR; Sacchettini JC; Young K; Olsen DB; Parish T
BMC Res Notes; 2018 Jun; 11(1):416. PubMed ID: 29954459
[TBL] [Abstract][Full Text] [Related]
11. Genome Mining of Streptomyces atratus SCSIO ZH16: Discovery of Atratumycin and Identification of Its Biosynthetic Gene Cluster.
Sun C; Yang Z; Zhang C; Liu Z; He J; Liu Q; Zhang T; Ju J; Ma J
Org Lett; 2019 Mar; 21(5):1453-1457. PubMed ID: 30746943
[TBL] [Abstract][Full Text] [Related]
12. Rescrutiny of the sansanmycin biosynthetic gene cluster leads to the discovery of a novel sansanmycin analogue with more potency against Mycobacterium tuberculosis.
Shi Y; Wang X; He N; Xie Y; Hong B
J Antibiot (Tokyo); 2019 Oct; 72(10):769-774. PubMed ID: 31341273
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum.
Kiefer A; Bader CD; Held J; Esser A; Rybniker J; Empting M; Müller R; Kazmaier U
Chemistry; 2019 Jul; 25(37):8894-8902. PubMed ID: 31012978
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.
Kling A; Lukat P; Almeida DV; Bauer A; Fontaine E; Sordello S; Zaburannyi N; Herrmann J; Wenzel SC; König C; Ammerman NC; Barrio MB; Borchers K; Bordon-Pallier F; Brönstrup M; Courtemanche G; Gerlitz M; Geslin M; Hammann P; Heinz DW; Hoffmann H; Klieber S; Kohlmann M; Kurz M; Lair C; Matter H; Nuermberger E; Tyagi S; Fraisse L; Grosset JH; Lagrange S; Müller R
Science; 2015 Jun; 348(6239):1106-12. PubMed ID: 26045430
[TBL] [Abstract][Full Text] [Related]
15. Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
Choules MP; Wolf NM; Lee H; Anderson JR; Grzelak EM; Wang Y; Ma R; Gao W; McAlpine JB; Jin YY; Cheng J; Lee H; Suh JW; Duc NM; Paik S; Choe JH; Jo EK; Chang CL; Lee JS; Jaki BU; Pauli GF; Franzblau SG; Cho S
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602512
[TBL] [Abstract][Full Text] [Related]
16. Solid-Phase Synthesis of Wollamide Cyclohexapeptide Analogs.
Prior AM; Sun D
Methods Mol Biol; 2020; 2103():175-187. PubMed ID: 31879925
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities.
Barbie P; Kazmaier U
Org Biomol Chem; 2016 Jul; 14(25):6036-54. PubMed ID: 27241518
[TBL] [Abstract][Full Text] [Related]
18. Chrysomycins, Anti-Tuberculosis C-Glycoside Polyketides from
Yu J; Guo H; Zhang J; Hu J; He H; Chen C; Yang N; Yang F; Lin Z; Dai H; Ouyang L; Liu C; Lei X; Zhang L; Zhu G; Song F
Mar Drugs; 2024 Jun; 22(6):. PubMed ID: 38921570
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Structure-Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin.
Kienle M; Eisenring P; Stoessel B; Horlacher OP; Hasler S; van Colen G; Hartkoorn RC; Vocat A; Cole ST; Altmann KH
J Med Chem; 2020 Feb; 63(3):1105-1131. PubMed ID: 31904960
[TBL] [Abstract][Full Text] [Related]
20. Three antimycobacterial metabolites identified from a marine-derived Streptomyces sp. MS100061.
Chen C; Wang J; Guo H; Hou W; Yang N; Ren B; Liu M; Dai H; Liu X; Song F; Zhang L
Appl Microbiol Biotechnol; 2013 May; 97(9):3885-92. PubMed ID: 23324803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
